India's pharma innovation pipeline grows 1.5x with funding boost
pre-market1 source ↓written by the desknot a recommendation
- discovery pipeline expanding
- 1.5 times
- 1,095 programmes
- 195 companies
- capital funding surged
- 2.1 times
- in FY26
- $731 million
India's pharmaceutical sector is evolving, with its drug discovery pipeline expanding 1.5 times to 1,095 programmes across 195 companies. Private equity and venture capital funding surged 2.1 times to $731 million in FY26, indicating a robust shift towards innovation-driven growth. This trend may enhance investor interest in the sector.
• 10 novel drug assets developed in the last decade
• Biotech startups increased from 1,500 to 2,400
• Pharmaceutical patent families from India on the rise
The report highlights a promising future for India's pharma landscape.
Not investment advice. For informational purposes only.